Diagnósticos da América S.A. (BVMF:DASA3)

Market Cap	4.00B +85.0%
Revenue (ttm)	11.17B -27.1%
Net Income	-1.15B
EPS	-0.92
Shares Out	1.25B
PE Ratio	n/a
Forward PE	21.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,191,600
Average Volume	1,706,580
Open	3.090
Previous Close	3.140
Day's Range	3.020 - 3.210
52-Week Range	1.180 - 4.770
Beta	0.15
RSI	43.58
Earnings Date	May 12, 2026

About Diagnósticos da América

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was f...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1961
• Employees: 26,255
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DASA3

Financial Performance

In 2025, Diagnósticos da América's revenue was 11.17 billion, a decrease of -27.10% compared to the previous year's 15.32 billion. Losses were -1.15 billion, -3.92% less than in 2024.